참고문헌
- Kasper HU, Drebber U, Dries V, Dienes HP. Liver metastases: incidence and histogenesis. Z Gastroenterol 2005;43:1149-57.
- Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES. Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer 2009;115:752-9. https://doi.org/10.1002/cncr.24081
- Haddad AJ, Bani Hani M, Pawlik TM, Cunningham SC. Colorectal liver metastases. Int J Surg Oncol 2011;2011:285840.
- Biasco G, Derenzini E, Grazi G, et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 2006;32:214-28. https://doi.org/10.1016/j.ctrv.2005.12.011
- Dawood O, Mahadevan A, Goodman KA. Stereotactic body radiation therapy for liver metastases. Eur J Cancer 2009;45:2947-59. https://doi.org/10.1016/j.ejca.2009.08.011
- Kim MS, Kim W, Park IH, et al. Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery. Radiat Oncol J 2015;33:265-75. https://doi.org/10.3857/roj.2015.33.4.265
- Folkert MR, Timmerman RD. Stereotactic ablative body radiosurgery (SABR) or stereotactic body radiation therapy (SBRT). Adv Drug Deliv Rev 2017;109:3-14. https://doi.org/10.1016/j.addr.2016.11.005
- Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13:8-10. https://doi.org/10.1200/JCO.1995.13.1.8
- Niibe Y, Hayakawa K. Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol 2010;40:107-11. https://doi.org/10.1093/jjco/hyp167
- Seo YS, Kim MS, Yoo HJ, Jang WI. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer. World J Gastroenterol 2014;20:2005-13. https://doi.org/10.3748/wjg.v20.i8.2005
- Cheung P. Stereotactic body radiotherapy for oligoprogressive cancer. Br J Radiol 2016;89:20160251. https://doi.org/10.1259/bjr.20160251
- Westover KD, Iyengar P, Sharma AN, Timmerman R. SABR for aggressive local therapy of metastatic cancer: a new paradigm for metastatic non-small cell lung cancer. Lung Cancer 2015;89:87-93. https://doi.org/10.1016/j.lungcan.2015.04.009
- Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer. Oncotarget 2015;6:8491-524.
- Eccles CL, Patel R, Simeonov AK, Lockwood G, Haider M, Dawson LA. Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2011;79:602-8. https://doi.org/10.1016/j.ijrobp.2010.04.028
- Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94. https://doi.org/10.1259/0007-1285-62-740-679
- Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16. https://doi.org/10.1093/jnci/92.3.205
- Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multiinstitutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-8. https://doi.org/10.1200/JCO.2008.19.6329
- van der Pool AE, Mendez Romero A, Wunderink W, et al. Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 2010;97:377-82. https://doi.org/10.1002/bjs.6895
- Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009;27:1585-91. https://doi.org/10.1200/JCO.2008.20.0600
- Yamashita H, Onishi H, Matsumoto Y, et al. Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients. Radiat Oncol 2014;9:112. https://doi.org/10.1186/1748-717X-9-112
- Andratschke NH, Nieder C, Heppt F, Molls M, Zimmermann F. Stereotactic radiation therapy for liver metastases: factors affecting local control and survival. Radiat Oncol 2015;10:69. https://doi.org/10.1186/s13014-015-0369-9
- Berber B, Ibarra R, Snyder L, et al. Multicentre results of stereotactic body radiotherapy for secondary liver tumours. HPB (Oxford) 2013;15:851-7. https://doi.org/10.1111/hpb.12044
- Klement RJ, Guckenberger M, Alheid H, et al. Stereotactic body radiotherapy for oligo-metastatic liver disease: influence of pre-treatment chemotherapy and histology on local tumor control. Radiother Oncol 2017;123:227-33. https://doi.org/10.1016/j.radonc.2017.01.013
- Ahmed KA, Fulp WJ, Berglund AE, et al. Differences between colon cancer primaries and metastases using a molecular assay for tumor radiation sensitivity suggest implications for potential oligometastatic SBRT patient selection. Int J Radiat Oncol Biol Phys 2015;92:837-42. https://doi.org/10.1016/j.ijrobp.2015.01.036
- Rule W, Timmerman R, Tong L, et al. Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol 2011;18:1081-7. https://doi.org/10.1245/s10434-010-1405-5
- Vautravers-Dewas C, Dewas S, Bonodeau F, et al. Imageguided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? Int J Radiat Oncol Biol Phys 2011;81:e39-47. https://doi.org/10.1016/j.ijrobp.2010.12.047
- Aitken KL, Tait DM, Nutting CM, Khabra K, Hawkins MA. Riskadapted strategy partial liver irradiation for the treatment of large volume metastatic liver disease. Acta Oncol 2014;53:702-6. https://doi.org/10.3109/0284186X.2013.862595
- Takeda A, Sanuki N, Tsurugai Y, Oku Y, Aoki Y. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions. J Radiat Res 2016;57:400-5. https://doi.org/10.1093/jrr/rrw029
- Kinj R, Bondiau PY, Francois E, et al. Radiosensitivity of colon and rectal lung oligometastasis treated with stereotactic ablative radiotherapy. Clin Colorectal Cancer 2016 Aug 31 [Epub]. http://doi.org/10.1016/j.clcc.2016.08.003.
피인용 문헌
- Feasibility of split-course stereotactic ablative radiotherapy for oligometastases vol.48, pp.6, 2018, https://doi.org/10.1093/jjco/hyy062
- Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases vol.9, pp.12, 2018, https://doi.org/10.1111/1759-7714.12880